Biomet Inc. is facing over 1,000 lawsuits involving the M2a-Magnum and M2a-38 hip implants. In February 2014, Biomet agreed to pay $56 million to settle hundreds of cases. Plaintiffs allege that the metal-on-metal design is defective because it can shed toxic particles of chromium and cobalt into the hip, resulting in severe pain, failure of the implant, and revision surgery.
Biomet Hip Implant Class Action Information
Biomet Inc. agreed to pay $56 million in compensation and attorneys’ fees to resolve hundreds of lawsuits involving the Biomet M2a-Magnum and M2a-38 metal-on-metal hip replacements. The settlement would award a base payment of $200,000 for each qualifying plaintiff, though higher awards may be granted in some cases.
These lawsuits are not part of a class action lawsuit against Biomet. Instead, over 1,000 individual lawsuits have been centralized in a federal Multi-District Litigation (MDL No. 2391) in the U.S. District Court for the Northern District of Indiana.
What is the problem?
The Schmidt Firm, PLLC is nationally recognized as a class-action law firm, but we are not filing a Biomet hip implant class action. We file individual lawsuits on behalf of men and women who developed severe complications from metal-on-metal hip implants. These complications include chronic pain, inflammation, swelling, metal poisoning (metallosis), systemic reactions, limited mobility, and revision surgery.
About Class Actions
Class actions are a useful way to resolve legal claims affecting thousands of people. They are a good way to collectively seek reimbursement for purchasing a defective product, because it wouldn’t make financial sense for everyone to file a lawsuit alone.